← Leaderboards
Emmanouil Brilakis
Ut Southwestern Medical Center
$1,051,385
Attributed
$1,051,385
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.4K · FY2010–15$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,051,385 · 1
VA$0 · 1
By mechanism
R01$1,051,385 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ying Xian$6,460,808
- Anand Kumar Rohatgi$8,142,204
- Abhimanyu Garg$28,553,253
- Samir M Parikh$19,761,844
- Ambarish Pandey$2,438,022
Others in their field
Top investigators on “Lipids”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Alan M Fogelman · University Of California Los Angeles$57,458,120
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Adrian Hernandez · Duke University$50,769,596
- Garret A Fitzgerald · University Of Pennsylvania$50,340,498
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
Research focus
LipidsIntravascular UltrasonographyGraft FailureAcute Coronary SyndromeImageIndexingFollow-UpFailure (Biologic Function)BypassCaliberHospitalizationAtherosclerosisCessation Of LifeIncidenceArterial Fatty StreakDoseEventCoronaryCoronary AngiographyCoronary ArteriosclerosisCoronary ArteryCoronary Artery BypassCardiacMorbidity - Disease Rate
Grant awards (8)
Prasugrel for prevention of early saphenous vein graft thrombosis$0
I01 · FY2015 · VA · contact PI
Prasugrel for prevention of early saphenous vein graft thrombosis$0
I01 · FY2014 · VA · contact PI
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis$237,505
R01 · FY2013 · HL · contact PI
Prasugrel for prevention of early saphenous vein graft thrombosis$0
I01 · FY2013 · VA · contact PI
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis$249,480
R01 · FY2012 · HL · contact PI
Prasugrel for prevention of early saphenous vein graft thrombosis$0
I01 · FY2012 · VA · contact PI
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis$252,000
R01 · FY2011 · HL · contact PI
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis$312,400
R01 · FY2010 · HL · contact PI